A Japanese team pinned down when CD4 killer T cells start to expand: right around age 100. The study needed blood from ten donors over 110, and the cohort that could supply them took thirty years to build.
Yamanashi wants to charge for off-season helicopter rescues on Mount Fuji, 8,000 yen per five minutes. Its own document calls it a package against reckless climbing. Is free rescue too cheap, or does a meter delay calls?
A decryption tool built by Japan's police has restored about 20 million files for 41 companies since February 2024. It is free and used in more than 100 countries, and it still reaches only a fraction of victims.
A 200,000-yen temple room and a 100-million-yen tax finding surfaced at Koyasan in the same week. Where that price actually sits, why Japanese law taxes the bed but not the offering, and how to book a night.
JR East opened public voting on three successors to the Suica penguin, and about 58% of Japanese posts turned negative. What they object to, why the 2018 Takanawa Gateway vote poisoned the well, and why it may not last.
Japan culled 1,381,700 deer and wild boar in fiscal 2024, and 5.6 percent of that mass became meat. The rest goes to a hole in the ground or an incinerator, and the capacity is not there. Scotland does it differently.
Get out of bed if you are not asleep in 20 minutes. That rule belongs to CBT-I, which a University of Tokyo analysis puts at 41% remission against 28% for pills. Japan covered it in June 2026, after rejecting it in 2024.
A 50-stop organ built by 18th-century methods has been finished at a Yamazaki Baking hall near Tokyo. It takes five people to sound right, at a moment when Japan's public halls are struggling to keep theirs.
Sushi shop bankruptcies in Japan rose 45.5% in the first half of 2026, yet only 18.8% were losing money, the lowest in Teikoku Databank's 20 years. They are not failing. They close because nobody takes over.
Astellas and Kyowa Kirin are the first Japanese drugmakers to sign most-favored-nation pricing deals with Washington. A September 29 tariff deadline explains the timing, and Japanese prices sit inside the U.S. formula.
Japan recorded 86,473 IVF births in 2024, about 1 in 8 of its 686,173 births. Treatments fell to 550,265 while the multiple-birth rate rose to 4.15 percent, and the 2022 insurance reform helps explain both.